Other programs in our pipeline include potency-boosted CAR-NK cell therapies to address solid tumors that express novel surface markers.

Catamaran bio inc. Catamaran Bio is developing novel off-the-shelf CAR-NK cell therapies designed to treat a broad range of cancers including solid tumors. CAMBRIDGE MassCatamaran Bio Inc a biotechnology company developing allogeneic CAR-NK cell therapies to treat diseases with significant unmet medical need announced the appointment of Alvin Shih MD MBA as President and Chief Executive Officer. Catamaran Bio Inc in Cambridge Massachusetts is spun-off from medical school research labs at University of Minnesota and George Washington University.

Shih is an experienced biopharma executive with a track record of. Office 300 Technology Square 8th Floor Cambridge MA 02139. CAMBRIDGE Mass-- BUSINESS WIRE--Catamaran Bio announces appointment of Dr.

Our proprietary capabilities enable us to harness the natural cancer-fighting properties of NK cells and enhance and tailor their effectiveness with the power of synthetic biology and innovative non-viral cell engineering. Catamaran Bio is developing treatments for cancer based on natural killer cells in the immune system. Free and open company data on Massachusetts US company CATAMARAN BIO INC.

April 26 2021 Catamaran Bio Inc a biotechnology company developing allogeneic CAR-NK cell therapies to treat patients with significant unmet medical need today announced the appointment of Scott Holmes MS MBA as Chief Financial OfficerMr. Company number 001468962 201 WASHINGTON ST STE. Vipin Suri PhD MBA Chief Scientific Officer who has more than 20 years of biopharmaceutical experience including as a co-founder of Obsidian Therapeutics and Serien formerly Raze Therapeutics and earlier in R.

3900 CO SV HEALTH INVESTORS BOSTON MA 02108. CAMBRIDGE Mass--BUSINESS WIRE--Catamaran Bio Inc a biotechnology company developing allogeneic CAR-NK cell therapies to treat cancer today announced that the company has launched with 42. Subscribe to Catamaran Bio.

The leadership team at Catamaran Bio has deep expertise in cell therapy research and product development and the team includes. Technical scientific consultation or product development for others in the fields of biotechnology cell therapy and development of pharmaceuticals and. Holmes has 20 years of experience in finance strategy and operations including roles as Chief Financial Officer of.